|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
4R00CA134743-03
|
$233,147
|
$46,629
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$309,002
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-02
|
$330,349
|
$330,349
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
|
ANTICANCER DRUG DISCOVERY THAT TARGETS TUMOR HYPOXIA
|
5R01CA098787-08
|
$262,130
|
$65,533
|
NAGLE, DALE
|
UNIVERSITY OF MISSISSIPPI
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$9,723
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$1,243
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$2,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$88,043
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
$2,800
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
$15,437
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA
|
ZIABC011002
|
$76,634
|
$76,634
|
Khan, Javed
|
CCR (NCI)
|
|
|
Biology and Therapy of High Risk Neuroblastoma
|
5P01CA081403-13
|
$2,006,380
|
$2,006,380
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIABC011334
|
$343,873
|
$34,387
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Cancer Center Core Support Grant
|
3P30CA016086-36S1
|
$76,572
|
$1,531
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Cancer Center Core Support Grant
|
5P30CA016086-36
|
$7,071,992
|
$141,440
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S1
|
$140,000
|
$8,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-39S2
|
$75,000
|
$4,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-39
|
$3,816,425
|
$228,986
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA008748-47S1
|
$75,000
|
$1,500
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Cancer Center Support Grant
|
3P30CA008748-47S2
|
$49,732
|
$995
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Cancer Center Support Grant
|
3P30CA008748-47S3
|
$250,001
|
$5,000
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Cancer Center Support Grant
|
5P30CA008748-47
|
$13,185,550
|
$263,711
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Cancer Center Support Grant
|
2P30CA082103-14
|
$7,206,673
|
$72,067
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-14S1
|
$75,000
|
$750
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-14S2
|
$49,401
|
$494
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA082103-14S3
|
$499,996
|
$5,000
|
MCCORMICK, FRANK
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
Cancer Center Support Grant
|
3P30CA014599-37S1
|
$139,999
|
$1,400
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer Center Support Grant
|
3P30CA014599-37S2
|
$74,999
|
$750
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer Center Support Grant
|
5P30CA014599-37
|
$4,138,729
|
$41,387
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
|
Cancer Center Support Grant
|
1P30CA168524-01
|
$1,397,375
|
$13,974
|
JENSEN, ROY
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-34S1
|
$122,220
|
$3,667
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-34S2
|
$78,125
|
$2,344
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Cancer Center Support Grant (CCSG)
|
3P30CA021765-34S3
|
$52,084
|
$1,563
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Cancer Center Support Grant (CCSG)
|
5P30CA021765-34
|
$5,674,815
|
$170,244
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-02
|
$573,087
|
$418,354
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-18
|
$4,314,800
|
$431,480
|
ROBISON, LESLIE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-10S3
|
$176,626
|
$24,728
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
|
Children's Oncology Group Chair's Grant
|
7U10CA098543-10
|
$26,733,729
|
$3,742,722
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
|
Children's Oncology Group Statistics and Data Center Grant
|
7U10CA098413-10
|
$5,792,621
|
$810,967
|
ANDERSON, JAMES
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
Clinical Development of HU14.18-IL2 Targeted Therapy
|
5R01CA032685-28
|
$311,465
|
$155,733
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIASC010354
|
$636,237
|
$31,812
|
Widemann, Brigitte
|
CCR (NCI)
|
|
|
Columbia University Medical Center Minority-Based Community Clinical Oncology Pro
|
1U10CA167791-01
|
$796,302
|
$23,889
|
GRANN, VICTOR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
|
1R01CA164365-01A1
|
$364,407
|
$364,407
|
HSU, KATHARINE
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Combination therapy to inhibit neuroblastoma growth
|
5R01CA147792-03
|
$355,503
|
$355,503
|
RAO, JASTI
|
UNIVERSITY OF ILLINOIS
|
|
|
Community Clinical Oncology Program Research Base
|
2U10CA095861-11
|
$1,608,610
|
$241,292
|
POLLOCK, BRAD
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
5U10CA035157-29
|
$443,765
|
$35,501
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
ZIABC010592
|
$57,475
|
$40,233
|
Khan, Javed
|
CCR (NCI)
|
|
|
CONSTRUCTION AND TESTING OF A TRIVALENT VACCINE AGAINST NEUROBLASTOMA ADMINISTERE
|
1R43CA171392-01
|
$149,152
|
$149,152
|
LIVINGSTON, PHILIP
|
MABVAX THERAPEUTICS, INC.
|
|
|
Copy number variations (CNVs) in neuroblastoma
|
4R00CA151869-03
|
$249,000
|
$249,000
|
DISKIN, SHARON
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
2U10CA045418-26
|
$1,423,934
|
$14,239
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Total relevant funding to Neuroblastoma for this search: $27,138,562
|
